Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

NCT01276236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Kaposi's Sarcoma

Interventions

DRUG: Maraviroc

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]